Mechanistically, FBXL18 interacted with RPS15A and promoted its stability by polyubiquitination, followed by the upregulation of SMAD3 expression, leading to HCC tumorigenesis in vitro and in vivo. Here, SMAD3 is linked to hepatocellular carcinoma.